MannKind Corporation develops patient-focused drug therapies and innovative technology solutions.
We specialize in innovative technologies with proven ease-of-use and patient acceptance.
Needle-free, self-administered Inhalation Treatment Systems for both chronic and acute diseases.
Our Technosphere® technology can accommodate a wide variety of APIs required by specific drug therapies.
MannKind Corporation (NASDAQ and TASE: MNKD) is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. More
|Jun 28, 2017||MannKind Draws Remaining Funds under Mann Group Loan Arrangement… More|
|Jun 05, 2017||MannKind Engages Locust Walk to Explore Strategic Options for MannKind's Non-insulin Technosphere-based Pipeline Candidates… More|
|May 31, 2017||MannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil… More|